That puts a lot of pressure on the generics-and we have spoken to the companies at length earlier in the year before the launch of Mounjaro and Wegovy-that were earlier expected to launch at 7,000-8,000 for a month's dose," said leading diabetologist Rajiv Kovil
Wegovy, another FDA-approved medication, is primarily prescribed for chronic weight management in adults who are obese
The present recommendations of the American and European Diabetes Associations are currently updating their actual recommendation for the treatment algorithm for T2D ( Tirzepatide may also become an important pharmacological tool for the treatment of obesity if data from the SURMOUNT-1 trial are confirmed in other clinical studies (82)
Shamban agree that if youre interested in any kind of peptide, the safest approach is to work with a doctor, not an unverified online vendorand especially not the gray market
much over 25 and it can be too filling when your appetite is already low and you still want to eat a meal later
